Synthesis of novel dipyrido-1,4-thiazines

Heterocycles

Volumn 71, Issue 6, 2007, Pages 1347-1361

  Morak Mlodawska, Beata ^a   Pluta, Krystian ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34547780024     PISSN: 03855414     EISSN: None     Source Type: Journal    
DOI: 10.3987/com-07-11035     Document Type: Article

References (28)

1. Gupta R.R., and Kumar M. In: Gupta R.R. (Ed). Phenothiazines and 1,4-Benzothiazines - Chemical and Biological Aspects (1988), Elsevier, Amsterdam 1-161
2. Motohashi N., Kawase M., Kurihara T., Hever A., Nagy S., Ocsocvszki I., Tanaka M., and Molnar J. Anticancer Res. 16 (1996) 2525
3. Motohashi N., Kurihara T., Sakagami H., Szabo D., Csuri K., and Molnar J. Anticancer Res. 19 (1999) 1859
4. Motohashi N., Kawase M., Saito S., and Sakagami H. Curr. Drug Targets 1 (2000) 237
5. Amaral L., Vivieros M., and Kristiansen J.E. Trop. Med. Int. Health 6 (2001) 1016
6. Ordway D., Viveiros M., Leandro C., Bettencourt R., Almeida J., Martins M., Kristiansen J.E., Molnar J., and Amaral L. Antimicrob. Agents Chemother. 47 (2003) 917
7. Motohashi N., Kawase M., Satoh K., and Sakagami H. Curr. Drug Targets 7 (2006) 10557
8. Maki Y. Yakugaku Zasshi 77 (1957) 485
9. Takahashi T., and Maki Y. Yakugaku Zasshi 78 (1958) 417
10. Takahashi T., and Maki Y. Chem. Pharm. Bull. 6 (1958) 369
11. Rodig O.R., Collier R.E., and Schlatzer R.K. J. Med. Chem. 9 (1966) 116.
12. S. Rath, US Patent 2 789 978 (1957).
13. Okafor C. J. Org Chem. 32 (1967) 2006
14. E. Kopp, M. Strell, and R. Janson, German Patent DE 1 147 235 (1963).
15. Kopp E., and Strell M. Arch. Pharm. 295 (1962) 99
16. Morak B., Pluta K., and Suwinska K. Heterocyclic Commun. 8 (2002) 331
17. Morak B., Pluta K., Suwinska K., Grymel M., Bernard C., Schiltz M., Kloc C., and Siegrist T. Heterocycles 65 (2005) 2619
18. Dunne S.J., Summers L.A., and von Nagy-Felsobuki E.I. J. Heterocycl. Chem. 24 (1987) 851
19. Stahl E. Thin-layer chromatography (1969), Springer-Verlag, Berlin 508
20. Prediction of Activity Spectra for Substance, http://ibmc.msk.ru/PASS/
21. B. Morak-Mlodawska and K. Pluta, Unpublished data.
22. Franke U., Munk A., and Wiese M. J. Pharm. Sci. 88 (1999) 89
23. National Cancer Institute Developmental Therapeutics Program, In-Vitro Testing Results, Bethesda, USA.
24. Campbell J.B., Greene J.M., Lavagnino E.R., Gardner D.N., Pike A.J., Snoddy J., and Taylor E.C. J. Heterocycl. Chem. 23 (1986) 669
25. Kruger S., and Mann F.G. J. Chem. Soc. (1955) 2755
26. Altland H.W., and Molander G.A. J. Heterocycl. Chem. 14 (1977) 129
27. Okafor C., and Okaro U.C. Dyes & Pigments 16 (1991) 149
28. Burton A.G., Frampton R.D., Johnson C.D., and Katritzky A.R. J. Chem. Soc., Perkin Trans. 2 (1972) 1940